Kahimmune Therapeutics
Pre-clinicalKahimmune Therapeutics pioneers immunotherapy solutions targeting the dark genome for next-generation cancer treatment.
Founded
2020
Focus
Vaccines
About
Kahimmune Therapeutics pioneers immunotherapy solutions targeting the dark genome for next-generation cancer treatment.
Company Info
TypePrivate
Founded2020
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile